
Sign up to save your podcasts
Or
Now that we have therapies like vedolizumab and ustekinumab, many are wondering if there’s still a role for anti-TNFs in the treatment of IBD. Here to share his perspective and how he uses the multitude of available treatment options to his advantage is Dr. Jeffrey Basile, a gastroenterologist from Charleston GI.
4.7
1818 ratings
Now that we have therapies like vedolizumab and ustekinumab, many are wondering if there’s still a role for anti-TNFs in the treatment of IBD. Here to share his perspective and how he uses the multitude of available treatment options to his advantage is Dr. Jeffrey Basile, a gastroenterologist from Charleston GI.
7 Listeners
69 Listeners
1 Listeners
3 Listeners
3 Listeners
0 Listeners
6 Listeners
14 Listeners
0 Listeners
2,432 Listeners
3,332 Listeners
111,827 Listeners
1,090 Listeners
3,364 Listeners
7,928 Listeners
185 Listeners
248 Listeners
249 Listeners
366 Listeners
33 Listeners
16 Listeners
11 Listeners